In May 2015, the average time from submission to first decision for all original research papers submitted to Circulation Research was 15.49 days. 
INTRODUCTION
Precise spatio-temporal regulation of gene expression in cardiac myocytes is essential to meet the requirements during cardiac development as well as under pathophysiological conditions of the heart 1 . This requires adaptation of chromatin density by epigenetic processes like DNA methylation, histone modifications and ATP-dependent chromatin remodeling complexes 2 . Trimethylation of H3K4 as well as acetylation of H3K27 at promoter regions are linked to transcriptional activation, whereas DNA methylation and trimethylation of H3K27 at promoters and in gene bodies are associated with gene repression 3 . In addition, trimethylation of H3K36 is enriched at gene bodies of expressed genes linked to co-transcriptional splicing 4 . Cellular steady-state mRNA levels are affected by post-transcriptional splicing, polyadenylation or mRNA degradation 5 . All of these processes control the amount of mRNA available for protein translation. Therefore, analysis of nuclear unprocessed RNA is advisable to get direct insight into transcriptional activity 6 and its correlation with chromatin states. Most epigenetic studies in the heart focused on the analysis of cardiac tissue. Since cardiac myocyte nuclei represent only one third of cardiac nuclei in adult hearts and cell type composition changes during development of the heart and in disease 7 , cardiac myocyte-specific maps of epigenetic modifications and nuclear transcriptome data are needed. Cardiac myocytes can be isolated by enzymatic digestion of cardiac tissue at physiological temperatures 8 . As this might alter chromatin states and transcriptional activity we developed protocols that do not involve enzymatic steps and are carried out under cold conditions to maintain the in vivo situation.
In the present study we demonstrate purification of cardiac myocyte nuclei from several species including human. This enabled us to generate cardiac myocyte-specific genome-wide maps of several histone modifications and nuclear transcriptomes. The high proportion of detected nascent unspliced RNA allows novel insight into transcriptional activity of cardiac myocytes. The nuclear transcript abundancies greatly differ from cellular levels in cardiac myocytes. In addition, gene transcription could be predicted by a model incorporating data of several key histone modifications. Our results open new possibilities to analyze epigenetic signatures and transcriptional activity of cardiac myocytes in development and disease.
RESULTS

Method outline.
We developed a protocol for the isolation of highly pure cardiac myocyte nuclei from small tissue biopsies ( Figure 1 ). In contrast to traditional approaches involving enzymatic tissue dissociation to obtain cell suspensions 8 , the described procedures do not involve enzymatic steps and are carried out under cold conditions to maintain the in vivo epigenetic state. Furthermore, our protocol enables characterization of frozen cardiac samples from experimental animal models as well as cardiac tissue biopsies from patients. Sorting relies either on fluorescence-(FACS) or magnetic-assisted nuclei sorting (MACS). As we have previously shown, these sorted nuclei were suitable for epigenetic analysis 7 . These procedures were optimized for genome-wide analysis of epigenetic marks in cardiac myocyte nuclei derived from small amounts of tissue (Online Table I ). Furthermore, we established RNA sequencing of nuclear mRNA (nucRNA) to gain insight into transcriptional activity. To assess cellular steady-state RNA levels, we performed RNA sequencing from intact cardiac myocytes purified by FACS (Figure 1 ).
Staining of cardiac myocyte nuclei.
The basis of the presented method is the detection of pericentriolar material 1 (PCM1), a protein which in the heart is specifically bound to cardiac myocyte nuclei 7, 10 . To further prove the specificity of the peri-nuclear PCM1 staining in cardiac myocytes, we took advantage of a transgenic mouse model, in which a fusion protein of human histone H2B and mCherry (H2B-mCh) under control of the cardiac myocyte-specific Myh6 promoter labels exclusively all cardiac myocyte nuclei 9 . We stained cryosections of left ventricles from these transgenic mice with an antibody against PCM1 (Figure 2A (Figure 2A ). We also explored the cardiac myocyte-specific expression pattern in the scar area of infarcted hearts from H2B-mCh transgenic mice. Analysis of 4392 nuclei showed for 99.5% of the nuclei PCM1 and H2B-mCh signals ( Figure 2B ). Only negligible fractions of nuclei single positive for PCM1 (0.21 ± 0.1 % of nuclei) or for H2B-mCh (0.34 ± 0.2 %) were found ( Figure 2B ). Furthermore, we analyzed PCM1 staining in endothelial as well as smooth muscle cells. The glycocalyx of endothelial membranes was visualized by fluorescently labeled Griffonia simplicifolia lectin I 18 (GSL, Figure 2A , B), while smooth muscle cells were visualized by -smooth muscle actin (ACTA2) staining (Online Figure  II) . Analysis of 309 -smooth muscle actin positive cells did not reveal a single cell with perinuclear PCM1 staining (Online Figure II A, B) . In addition, endothelial cells as identified by presence of GSL and absence of H2B-mCh signals did neither show PCM1 staining in native hearts nor in hearts after myocardial infarction (Online Figure IIC, D) . 3 out of 1658 GSL positive cells were both H2B-mCh positive and PCM1 positive and thus could not be classified as cardiac myocytes or endothelial cells (Online Figure IIC, D) . We also tested PCM1 specificity in single cardiac cells after Langendorff cell isolation ( Figure 2C ). Very similar, we did not detect PCM1 staining in non-cardiac myocytes (H2B-mCh negative and non-rod shaped, 0 out of 173, Figure 2C ). All rod shaped cardiac myocytes were PCM1 and H2B-mCh positive. Some non-rod shaped cardiac myocytes (H2B-mCh positive) showed loss of the PCM1 signal, possibly due to cell death ( Figure 2C ).
Analysis and sorting of cardiac myocyte nuclei.
Flow cytometry experiments showed that PCM1 staining also labeled isolated nuclei ( Figure 2D -F). To evaluate whether the protocol was applicable to different species, we also analyzed human and rat hearts in addition to mouse hearts. In all three species PCM1 staining of cardiac myocyte nuclei was evident ( Figure 3A) . Remarkably, the proportion of PCM1 positive nuclei detected in frozen and fresh hearts was 99 ± 1.1 % (mean ± SEM, n =8) identical. Purification of cardiac myocyte nuclei by MACS was highly reproducible as assessed by flow cytometry (> 94 % purity, Figure 3B ). These results highlight that PCM1 enables isolation of cardiac myocyte nuclei from hearts of different species including frozen clinical samples.
Nuclear RNA-seq of cardiac myocytes.
We chose mouse cardiac myocyte nuclei to generate transcriptomes by paired-end sequencing using a random priming strategy. From two independent experiments we generated sequencing libraries with mean insert sizes of 253 and 343 bp. We obtained 80 million uniquely mapped reads. For comparison, we assessed gene expression in intact cardiac myocytes by RNA-seq (cellular RNA-seq). Langendorff digestion was used to isolate cardiac cells. The obtained cell suspension contained 19 ± 4% non-cardiac myocytes (n = 4, mean ± SEM, Online Figure IA) . Therefore, we further purified viable cardiac myocytes by FACS (Online Figure IB) and generated a library with a mean insert size of 312 bp and obtained 38 million uniquely mapped RNA-seq reads.
In contrast to cellular RNA-seq, nuclear RNA-seq showed high read coverage of intronic regions as illustrated in Figure 4A for the representative gene, phospholamban (Pln) ( Figure 4A ). Reads of cellular RNA-seq mapped predominantly into exonic regions of Pln ( Figure 4A ). However, nuclear RNAseq data showed a large fraction of unspliced nascent Pln transcripts ( Figure 4A ). Based on intronic reads we calculated the fraction of unspliced mRNAs for all genes with high read coverage (> 10 FPKM) and exon-exon junctions. This global analysis revealed that 60.8% of nuclear mRNAs were unspliced. In intact cardiac myocytes, the unspliced fraction was only 2.6% ( Figure 4B ). These findings confirmed our hypothesis that nuclear mRNA analysis is less affected by posttranscriptional modifications and thus enables insight into transcriptional activity. Remarkably, nuclear RNA-seq showed a more than 4-fold higher fraction of reads uniquely mapping to non-coding RNA transcripts as compared to cellular RNAseq ( Figure 4C , Online Table II) .
A drawback of nuclear RNA preparation is the likelihood of genomic DNA contamination. To quantify remaining DNA contamination we included two megabases of random sequences from the repeat-masked non-coding part of the genome in our bioinformatics analysis. In average, we detected 0.062 FPKM (0.049-0.074 FPKM, 95% confidence interval) in these regions. This value was regarded as the lower detection limit of our nuclear RNA-seq. 12,653 of 20,174 annotated coding genes showed transcriptional rates above this background ( Figure 4D) . Genes with the highest nuclear transcript levels were the cardiac myocyte genes troponin T type 2, α-myosin heavy chain, titin and myosin light-chain 2. Next we asked, whether nuclear and cellular mRNA profiles differ in cardiac myocytes. By visual inspection we identified natriuretic peptide A (Nppa) mRNA predominantly in the cellular RNA-seq ( Figure 5A ) whereas myosin heavy chain 7b (Myh7b) mRNA was mainly detected in nuclei ( Figure 5B ). In order to identify transcripts with the most differential abundance we calculated log 2 ratios of FPKM values between cellular and nuclear mRNAs for transcripts with expression > 1 FPKM in cardiac myocyte nuclei ( Figure 5C ). Cellular to nuclear RNA expression ratios differed over several orders of magnitude ( Figure 5C ). Gene ontology analysis of RNAs that were primarily expressed in cells as compared to nuclei (> 95 th percentile, Figure 5C ) showed significant enrichment for genes involved in energy metabolism ( Figure 5D ). On the other hand, mRNAs with higher abundance in nuclei (< 5 th percentile, Figure 5C ) showed an overrepresentation of genes associated with transcriptional regulation ( Figure 5E ).
Cell-type specificity of epigenetic and transcriptome data obtained from PCM1-sorted nuclei.
The heart consists of many different cell types including cardiac myocytes, fibroblasts, endothelial cells, smooth muscle cells and others 19 . Analysis of cardiac tissue thus shows the overlay of epigenetic and transcriptome signatures of different cardiac cell-types. We postulated that data obtained from PCM1-sorted nuclei were highly cardiac myocyte-specific. We compared our data from PCM1-positive cardiac myocyte nuclei with previously published data sets from cardiac tissue biopsies ( Figure  5A -D, Online Figure III) 14, 16, 20 . Figure 5 shows the results of the representative cardiac myocyte-specific gene myosin light chain 3 (Myl3) and the mesenchymal non-cardiac myocyte gene vimentin (Vim) 21 . In cardiac myocyte nuclei, the promoter region of Myl3 was enriched for acetylation of lysine 27 of histone 3 (H3K27ac, Figure 6A ). Acetylation of H3K27 is an epigenetic hallmark of active genomic regions 22 . In contrast, no H3K27ac signal could be detected in the promoter region of Vim in cardiac myocyte nuclei ( Figure 6B ). On the other hand, the Vim promoter was enriched for trimethylated H3K27, a mark that is considered to be an indicator of gene silencing 23 ( Figure 6B ). This repressive mark was absent in the promoter region of Myl3 in cardiac myocyte nuclei ( Figure 6A ). These results were in line with RNA-seq data revealing that Myl3 but not Vim was expressed in cardiac myocyte nuclei ( Figure 6A , B). Analysis of heart tissue showed gene expression of both genes and a mixture of active and inactive histone marks ( Figure 6C, D) . In addition, CpG methylation profiles of cardiac myocytes showed a clear topology as compared to profiles obtained from cardiac tissue biopsies ( Figure 6A-D) . Previously reported cardiac myocyte-specific demethylation of the genic region of Myl3 7 was only visible in cardiac myocyte nuclei but not in total heart samples ( Figure 6A , C). The obtained results were further validated by analysis of the endothelial cell gene angiotensin-converting enzyme (Ace) 24 and the fibroblast gene collagen alpha-2(I) chain (Col1a2) 25 (Online Figure III) . We compared our ChIP-seq data with data derived from in-vitro differentiated cardiac myocytes 13 to confirm validity. Similar enrichment profiles of histone modifications were observed for representative cardiac myocyte genes as well as for averages of genes grouped according to quantiles of expression in cardiac myocyte nuclei (Online Figure IV) . Differences were observed regarding non-cardiac myocyte marker genes and histone peaks adjacent to developmental genes (Online Figure IV) .
We asked which gene promoters were active according to acetylation of H3K27 in cardiac myocyte nuclei and in cardiac tissue. Therefore, we identified all promoters overlapping with an H3K27ac peak in hearts and in cardiac myocyte nuclei, respectively. We could identify 10,123 active promoters in hearts ( Figure 7A, C) . 936 of these lacked H3K27ac in cardiac myocyte nuclei, indicating that they were not active in cardiac myocytes but in other cardiac cell types ( Figure 7A ,C, black section). Gene ontology classification of H3K27ac ChIP-seq peaks detected in heart tissue but not in cardiac myocyte nuclei ( Figure 7C ) showed association with extracellular matrix organization, vascular development, regulation of immune system processes and cell migration (p < 10 -10 , Figure 7B ). This suggests that these H3K27ac signals originate from cardiac fibroblasts, endothelial cells or immune cells but not from cardiac myocytes. Analysis of these promoter regions showed enrichment for H3K27me3 in hearts as well as in cardiac myocyte nuclei ( Figure 7D ). Promoters active in hearts and cardiac myocytes ( Figure 7D , grey box) were depleted for H3K27me3 in cardiac myocytes. In contrast, results obtained from hearts showed enrichment for H3K27me3, probably due to silencing of these genes in non-cardiac myocytes ( Figure 7D , grey box).
Histone marks are predictive for transcription in cardiac myocytes.
We extended the analysis to further histone marks to get a more detailed picture. Previous studies showed that H3K36me3 is tightly linked to active transcription and peaks in gene bodies of active genes 11, 26 . We performed ChIP-seq experiments for the histone mark H3K36me3 in purified cardiac myocyte nuclei. We generated 22 million uniquely mapped readscing. In addition, we reanalyzed our previously published ChIP-seq data and asked which epigenetic marks were most predictive for cardiac myocyte transcription.
The tropomyosin 1 gene (Tpm1) encodes for a protein of the contractile apparatus 27 . It showed the typical epigenetic signature of a highly expressed gene ( Figure 8 ). Several isoforms of Tpm1 are annotated (Online Figure V) . Previous studies have shown that Tpm1 isoforms are expressed in different cell-types 27 . For a proper analysis of the interplay of chromatin features and RNA transcription it is crucial to identify the expressed isoform(s). We used nuclear RNA-seq reads from the spliced fraction to determine genome-wide exon-exon junctions and selected the main cardiac myocyte isoform of each gene for further analysis steps. In cardiac myocyte nuclei, only one Tpm1 isoform was detected (transcript 8, Online Figure . In a previous study we showed that low levels of gene body CpG methylation were characteristic for highly expressed cardiac myocyte genes 7 . In agreement with these results, large domains of the gene body of Tpm1 showed strong demethylation of CpGs with lowest levels of DNA methylation in the 5´-region (Online Figure V ). These data demonstrate that specific histone patterns mark expression of gene isoforms in cardiac myocytes.
In order to correlate transcript levels with histone marks, the genomic regions decorated by specific histone marks in cardiac myocyte nuclei were identified. Coding genes showed a clear pattern with marking of promoters of expressed genes by H3K27ac and H3K4me3 and of gene bodies by H3K4me1 and H3K36me3 (Online Figure VI) . Furthermore genes lacking these marks were marked by H3K27me3 in genic regions (Online Figure VI) . These genomic locations were selected for quantitative analysis.
To test if histone marks are predictive for nuclear mRNA expression we ranked all coding genes according to expression level. Genes not expressed in cardiac myocyte nuclei (< 0.062 FPKM, gene expression rank > 12,653) showed high H3K27me3 enrichment ( Figure 8B ). These genes were depleted for the active marks H3K4me3, H3K4me1, H3K36me3 and H3K27ac. Expressed genes gained active histone marks concordant with expression levels and lost H3K27me3 ( Figure 8B ).
These data prompted us to analyze the predictive information of the individual marks for transcriptional activity. Linear modeling of transcription from individual histone marks showed a significant positive correlation with measured nucRNA levels in case of H3K4me1, H3K4me3, H3K27ac and H3K36me3 (p < 0.001, Figure 8C ). A negative correlation with gene expression was observed for H3K27me3 (p < 0.001). H3K27ac contained the highest predictive information for a single histone mark. 70% of nucRNA expression differences could be explained by enrichment of H3K27ac at promoter regions ( Figure 8C ). The predictive power of the model was further improved to 78% by addition of results from assessed histone marks ( Figure 8C, D) . A scatter plot of predicted and measured nuclear RNA showed a large overlap for expressed as well as not-expressed genes. A linear correlation of gene expression values obtained from this prediction with cellular and heart RNA-seq data (Online Figure VII) yielded 74% and 71% (Online Figure VII) , respectively. Remarkably, the prediction was especially weaker in case of expressed genes. This was even more evident in case of non-cardiac data sets 20 further reducing the strength of correlation to 39-42% (Online Figure VII) .
DISCUSSION
We provide detailed methods for the in depth analysis of epigenetic modifications in cardiac myocytes. Furthermore, we present -for the first time -a technique to study nascent RNA transcripts of cardiac myocytes. Fresh as well as frozen cardiac tissue from different species including human can be purified using our workflow.
To date most epigenetic and transcriptome studies in cardiovascular research have analyzed cardiac tissue biopsies 31 . Epigenetic and gene expression signatures are highly cell type-specific 32 . Therefore, analysis of tissues consisting of complex cell type mixtures may lead to ambiguous results. Indeed, changes in cellular composition itself may lead to varying results 32 . This point should not be neglected in heart research, since several conditions are known to affect the cellular composition of the heart. For example, pathophysiological conditions like cardiac pressure overload or myocardial infarction induce cellular changes as part of cardiac remodeling 33, 34 . These changes involve apoptosis of cardiac myocytes, proliferation of fibroblasts and endothelial cells as well as invasion of inflammatory cells.
The importance to consider these alterations is highlighted by a recent manuscript reanalyzing previously published data sets of age-associated epigenetic changes in the blood. Most of the observed variability could be explained simply by cellular composition 35 . Our recent findings support the significance of altered cellular composition for cardiac epigenetic studies 7 . Significant differences of CpG methylation levels in biopsies of hypertrophic and healthy hearts were caused by disease-associated loss of cardiac myocytes and increased abundance of fibroblasts and other non-cardiac myocyte cells 7 . Analysis of complex tissues like hearts may also lead to misinterpretation of chromatin signatures. Coexistence of repressive and active marks on the same allele has been observed in cell types with restricted differentiation potency or pluripotency 36 . Remarkably, this bivalency could not be observed in our datasets of adult cardiac myocytes. ChiP-seq data from hearts resemble the picture of bivalency, but it is very likely that the signals of the active and inactive marks originate from different cell-types.
These facts underscore the need for cell type-specific studies. To meet this demand we developed methods for the epigenetic and transcriptome analysis of purified cardiac myocyte nuclei. We and others reported PCM1 as a marker of cardiac myocyte nuclei in different species 7, 10 . In the present manuscript, different immunohistochemistry quantification strategies in healthy, transgenic and diseased hearts show that > 98 % of cardiac myocyte nuclei are positive for PCM1. These results are in very good agreement with our previously reported FACS data reported for human cardiac myocytes 37 . Our whole genome data of nuclear mRNA expression and epigenetic marks further support the validity of PCM1 as a cardiac myocyte-specific marker.
In contrast to traditional approaches involving enzymatic tissue dissociation to obtain cell suspensions 8 , the described procedures do not involve enzymatic steps and are carried out under cold conditions to maintain the in vivo epigenetic state. Our method is applicable to different developmental and disease stages of several species including frozen clinical samples without protocol modifications.
The initial step of the workflow is disruption of cardiac biopsies and purification of nuclei. The described tissue disruption and purification procedures ensure efficient and reliable isolation of nuclei from frozen as well as fresh cardiac biopsies. Isolated nuclei can be sorted by FACS. In addition, we established magnetic-assisted sorting of antibody-labeled nuclei (MACS) which enables processing of samples in parallel. Both methods yielded highly pure preparations.
To date several studies performed deep sequencing of the cardiac transcriptome 38, 39 . In the present manuscript, we studied for the first time the nuclear transcriptome of cardiac myocytes. In comparison to cellular RNA, nucRNA represents freshly transcribed (nascent) mRNA and therefore correlates more closely with transcriptional activity. The validity of this assumption was proven by the large fraction of detected unspliced mRNAs and is in good agreement with previous reports assessing nucRNA in other cell-types 6, 40 . Our data sets enabled us for the first time to identify the entire set of genes transcribed in cardiac myocytes. Epigenetic data confirmed these results since transcribed genes showed an epigenetic signature distinct from non-expressed genes.
Following transcription, several mechanisms modulate mRNA abundance. Comparing nuclear and cellular mRNA levels in cardiac myocytes revealed distinct patterns of expression. Remarkably, a large fraction of metabolic genes seems to accumulate in the cytosol. Several mechanisms could account for these differences including post-transcriptional processing, mRNA decay and miRNA mediated degradation 5, 11, 41 .
Next, we proposed a model to deduce quantitatively nuclear transcript levels from epigenetic data. The highest informative value among the assessed histone modifications had H3K27ac. To improve the accuracy of the model, we combined the results of five key histone marks. This model explained 78% of gene expression alteration by epigenetic marks. Comparable results have been obtained in different cell lines 11, 42, 43 . A cross-comparison of the predictive model of cardiac myocyte gene expression with measured RNA levels in non-cardiac tissues showed a weak correlation (Online Figure VII) . This underscores that the chromatin state of promoter and genic regions is a major determinant of cell-type specific transcriptional activity. Factors explaining the remaining transcriptional variability include varying activity of enhancers 44 and transcription factors 45 . This tight link of chromatin state and transcriptional activity can only be uncovered in cell-type specific data sets.
Nuclei purified with the proposed protocol are principally suitable to study other nuclear processes in cardiac myocytes. The proposed protocol opens new possibilities to study gene transcription and epigenetic mechanisms in cardiac myocytes from different species and developmental stages including clinical samples. This will be of great value to pave the way to a better understanding of cardiac myocyte transcription in development and disease. 
Novelty and Significance
What Is Known?
 The cellular composition of the heart is changing during development and disease.
 Control of gene expression is essential for proper function of cardiac myocytes.
 Epigenetic control of transcription is highly cell-type specific.
What New Information Does This Article Contribute?
 This study provides a method for purification of cardiac myocyte nuclei from frozen heart tissue of several species.
 We have identified and quantified mRNAs transcribed in cardiac myocytes on the nuclear and cellular level.
 Chromatin state is a main predictor of transcriptional activity in cardiac myocytes.
Regulation of gene expression involves several processes including epigenetic control of transcriptional activity. However, the precise molecular mechanisms in cardiac myocytes in vivo are unknown. Thus, the aim of the present study was to establish epigenetic and transcriptomic profiling of purified cardiac myocyte nuclei from heart tissue. Cardiac myocyte nuclei were identified upon staining with an antibody against PCM1. Extensive validation demonstrated very high degrees of specificity and sensitivity of PCM1 staining for cardiac myocyte nuclei. Using this technique we identified RNA transcripts expressed in cardiac myocyte nuclei in vivo. A quantitative analysis of five histone marks was performed in order to define the chromatin state of cardiac myocyte genes. Chromatin status correlated significantly better with nuclear RNA than cellular RNA profiles. This integrative analysis indicated a major impact of the chromatin state on transcriptional activity in cardiac myocytes. Thus, cardiac myocyte-specific sorting of nuclei is a reliable method to investigate epigenetic and transcriptional processes in cardiac myocytes.
The findings may open new mechanistic insight into the interplay of epigenetic mechanisms and transcription in cardiac myocytes during development and under pathophysiological conditions.
SUPPLEMENTAL MATERIAL DETAILED METHODS
Animal procedures
All animal procedures were approved by the responsible animal care committee (Regierungspräsidium Freiburg, Germany) and the Landesamt für Natur, Umwelt und Verbraucherschutz, Recklinghausen, Germany); they conformed to the Guide for the Care and Use of Laboratory Animals published by the National Academy of Sciences 2011. Twelve weeks old male C57BL/6N mice, twelve weeks old female Myh6-H2B-mCherry transgenic mice 1 and Wistar rats were used. Experimental infarction by ligation of the left anterior descending coronary artery was performed as previously described 1 . Mice were sacrificed 10 days after infarction and hearts were perfusion fixed with 4% paraformaldehyde solution. After further fixation overnight, the hearts were treated with 20% sucrose solution and mounted in O.C.T compound.
Human cardiac biopsies
Left ventricular biopsies from non-failing hearts were used for cardiomyocyte nuclei isolation. These investigations were approved by the ethics committee of the University of Freiburg.
Immunohistochemistry
Frozen, formaldehyde fixed adult mouse hearts were sectioned into 10 µm slices with a cryotome CM 3050S (Leica). Sections of mouse hearts were subjected to antigen retrieval (10 mM sodium citrate, pH 6.0, was performed in a KOS Microwave (Milestone, program: 4 min 70°C, 3 min 85°C, 4 min 90°C, 5 min 93°C). Cryo-sections were stained with antibodies against PCM1 (HPA023370, Sigma 1:1000 or G2000, Cell Signaling, 1:100). Isolated cardiomyocytes were stained with antibodies against α-actinin (1:400, clone EA-53, Sigma-Aldrich) and PCM-1 (G2000, Cell Signaling, 1:100). Primary antibodies were visualized by secondary antibodies conjugated to Cy2 and Cy5 (Life Technologies, 1:1000, Jackson ImmunoResearch 1:400). Griffonia simplicifolia lectin I (GSL-I, Vector Laboratories) or α-smooth muscle actin (ACTA2, A5228, Sigma 1:800) staining was used to visualize the glycocalyx of endothelial cells or α-smooth muscle cells, respectively. Nuclei were stained with DAPI (4',6-diamidino-2-phenylindole, Life technologies) and Hoechst 33342. For documentation an inverted fluorescence microscope (Axiovert 200; Carl Zeiss MicroImaging, Inc.) equipped with a slider module (ApoTome2) and an inverted confocal laser scanning microscope (Eclipse Ti, Nikon) were used. Images were generated with ZEN 2012 software (Zeiss) and the NIS Elements software (Nikon). For quantification of PCM1 positive or H2B-mCh positive nuclei in 10 µm thick tissue sections six 400 µm x 500 µm fields were analyzed per heart (n = 2). After experimental infarction at least eight fields (200 µm x 500 µm) within the border zone were analyzed for PCM1 positive or H2B-mCh positive nuclei (n = 2). Ventricular cells from adult mice were enzymatically isolated with 1 mg/ml (activity 0.199 U/mg) Collagenase B and 33 µg/ml Trypsin by Langendorff perfusion as previously described 1 . Isolated cells were fixated with 4% formaldehyde solution. Isolated adult cardiomyocytes and non-cardiomyocytes were quantified after generation of maximum intensity projections of z-stacks. At least 130 ventricular cardiomyocytes per heart (n = 4) were checked for the overlap of H2B-mCh expression and PCM1 staining.
Isolation of cardiac nuclei
Cardiac nuclei were isolated as previously described 2 . All steps of the protocol were carried out at ≤ 4 °C. Protease-inhibitors (cOmplete Protease Inhibitor Cocktail, Roche) and DDT (1 mM, dithiothreitol) were freshly prepared and added to all buffers. For the isolation of nuclear RNA, RNAsin (80 U/ml, Promega) was added to all buffers. For chromatin isolation sodium butyrate (10 mM) was added. Snap frozen cardiac tissue was thawed on ice and 3 ml lysis buffer (5 mM CaCl 2 , 3 mM MgAc, 2 mM EDTA, 0.5 mM EGTA, 10 mM Tris-HCL, pH 8) was added. The tissue was homogenized using a gentleMACS dissociator (Miltenyi) with gentleMACS M tubes (Miltenyi) using the protocol "protein_01". Next, 3 ml of lysis buffer supplemented with 0.4 % triton-X was added and the combined cell suspension was filtered through 40 µm gaze (BD Biosciences). The filter was washed with 2 ml lysis buffer including 0.2 % triton-X. The flow-through was centrifuged (1000 x g, 5min). The pellet was resuspended and overlayed on 1 M sucrose (3 mM MgAc, 10 mM Tris-HCl, pH 8). After centrifugation (1000 x g, 5 min) the pellet was resuspended in 500 µl staining buffer (PBS containing 5 % BSA and 0.2 % Igepal CA-630) and used for magnetic-assisted purification or FACS.
Magnetic-assisted sorting of cardiomyocyte nuclei
All steps of the protocol were carried out at ≤ 4°C. For magnetic-assisted sorting, cardiomyocyte nuclei were incubated with an anti-PCM1 antibody (1:1,000, Sigma) in staining buffer. After staining nuclei were centrifuged. Nuclei were resuspended with 20 µl anti-rabbit IgG MicroBeads (Miltenyi) and 80 µl MACS buffer (PBS containing 2 mM EDTA, 1 % BSA, 2 % skimmed milk powder) and incubated for 15°C. After addition of 900 µl MACS buffer the suspension was applied to MS columns (Miltenyi), washed with 3 ml MACS buffer and eluted. This step was repeated once using another MS column (Miltenyi). Cardiomyocyte nuclei were finally eluted in PBS containing 1 mM EDTA. Sorting purity was validated by flow cytometric analysis after staining with an Alexa647-labelled secondary antirabbit antibody (1:1,000, Life Technologies) and DAPI (1:1,000, Life Technologies) using a CyFlow Space (Partec).
Flow cytometric analysis and sorting of cardiac myocyte nuclei
Cardiomyocyte nuclei were incubated with an anti-PCM1 antibody (1:1000, HPA023370, Sigma) or isotype control IgG (1:10000, ab37415, Abcam) and Alexa-labeled secondary antirabbit antibodies (1:1000, Life technologies). For nuclei staining DAPI (1:1000, Life technologies) or Draq7 (1:200, Life technologies) were used. Nuclei were analyzed (CyFlow Space, Partec) or sorted (Bio-Rad S3, Bio-Rad) by flow cytometry.
Isolation of cardiac cells and sorting of viable cardiomyocytes
Adult mouse hearts were digested to obtain a single-cell suspension by retrograde perfusion 3, 4 with 15 ml Tyrode's solution supplemented with 25 mM butanedione monoxime, 2 mM CaCl 2 , 0.8 mg ml −1 collagenase B (Roche, Mannheim, Germany), 0.4 mg ml −1 hyaluronidase (Sigma) and 3 μg ml −1 trypsin (Sigma) for 12 min. The enzymatic digestion was stopped by addition of 20 ml buffer S (Tyrode's buffer, 5% FCS, 25 mM butanedione monoxime, 2 mM CaCl 2 ). Hearts were gently dissected into small pieces using a pair of forceps following repetitive pipetting (10-20x) using a serological pipette. The resulting suspension was filtered through 100 µm gaze (Greiner Bio-One) and centrifuged with low force (50 x g, 5 min, 4 °C). The pellet was resuspended in 4 ml buffer S (4 °C). Flow cytometric analysis and sorting of cardiomyocytes was carried out at 4 °C using a Bio-Rad S3 cell sorter. Cardiomyocytes and non-cardiomyocytes were visualized using the cellpermeable nucleic acid stain DRAQ5 (Cell Signaling Technology). Sorting of viable cardiomyocytes was performed after addition of the cell-impermeable nucleic acid dye DRAQ7 (Life Technologies). Cardiomyocytes were discriminated from other cardiac cells by high forward scatter (FSC) signals. Gates were selected to sort viable cardiomyocytes directly into RLT lysis buffer (Qiagen, Hilden, Germany).
ChIP-sequencing
ChIP-seq was performed as described previously with modifications 2, 5 . Purified cardiomyocyte nuclei were fixed with 1 % PFA (paraformaldehyde, Sigma) for 2 min at room temperature. Fixation was quenched by adding glycine to a final concentration of 125 mM. After washing with PBS for three times, nuclei were lysed in SDS buffer (50 mM Tris-HCl pH 8.0, 10 mM EDTA, 1 % SDS) supplemented with protease inhibitors (cOmplete Protease Inhibitor Cocktail, Roche). Chromatin was sonicated using a Bioruptor ® (Diagenode) with 30 cycles (30 s on/30 s off; high energy) to an average fragment size of 200 -400 bp. 200 µl Protein A Dynabeads (Life technologies) were washed with TE buffer (20 mM Tris-HCl pH 8.0, 2 mM EDTA) two times. Following the second wash step, beads were resuspended in 1 ml TE buffer containing 1 mg/ml tRNA (Sigma) and 1 mg/ml BSA (Roth) . After incubation for 2 h at 4 °C, beads were washed with TE buffer three times and finally resuspended in 200 µl TE. Chromatin concentration was adjusted to 50 ng/µl using SDS buffer. Next, chromatin was diluted 1:10 with dilution buffer (50 mM HEPES-KOH pH 7.5, 500 mM NaCl, 1 mM EDTA, 1 % Triton X-100, 0.1 % sodium deoxycholate, 0.1 % SDS, protease inhibitors) and precleared with 10 µl blocked beads for 1 h at 4 °C. 50 µl of preblocked chromatin served as input. For immunoprecipitation 2.5 µg of chromatin was incubated with an anti-H3K36me3 antibody (1 µg, ab9050, Abcam) overnight. The next day, 15 µl blocked beads were added and samples were incubated for 3 h at 4 °C. Immunocomplexes were washed for 5 min each with dilution buffer for two times, with wash buffer (10 mM Tris-HCl pH 8.0, 250 mM LiCl, 1 mM EDTA, 0.5 % IGEPAL CA-630, 0.5 % sodium deoxycholate) and finally with TE buffer (20 mM Tris-HCl pH 8.0, 2 mM EDTA) at 4 °C. Following magnetic separation, beads were resuspended in 160 µl elution buffer (100 mM NaHCO 3 , 1 % SDS) and immunocomplexes were eluted by incubation at room temperature for 15 min. This step was repeated with another 160 µl of elution buffer. The eluates were combined and treated with 20 ng/µl RNAse A (Sigma) for 30 min at 37 °C. Crosslinks were reversed by adding 0.5 µg/µl proteinase K (AppliChem) and incubation at 55 °C for 2.5 h. After this initial incubation, temperature was raised to 65 °C and incubated overnight. DNA was purified using phenol/chloroform followed by ethanol precipitation at -20 °C overnight. DNA was quantified using Quant-iT™ PicoGreen ® dsDNA Reagent (Life technologies) and 5 ng were used per library. NEBNext ® ChIP-seq Library Prep Master Mix Set for Illumina (NEB) was used for library preparation (15 PCR cycles). Libraries were sequenced on a HiSeq™ 2500 (50 bp, paired-end, Illumina). Data were deposited to the NCBI BioSample database (SRP033385).
Gene expression analysis
Total RNA was isolated from intact cardiomyocytes as previously described 2 or from cardiomyocyte nuclei from one adult mouse heart using RNeasy Micro Kit (Qiagen) including on-column DNAse digestion. Ribosomal RNA was depleted using the Low Input RiboMinus Eukaryote System v2 (Life technologies). Depleted RNA fragmented to approximately 200 bp fragments and was used for library construction (NEBNext ® Ultra RNA Library Prep Kit for Illumina, NEB). Size selection was performed with AMPure ® XP Beads (Beckman Coulter) according to the NEBNext ® Ultra RNA Library Prep Kit manual. 15 PCR cycles were used for amplification. Libraries were sequenced on a HiSeq 2500 (50 bp, paired-end, Illumina). Data were deposited to the NCBI BioSample database (SRP033386).
Bioinformatics analysis
All bioinformatics tools used in this study were used as part of the Galaxy platform 6 . The Mus musculus genome (mm9) and the annotation of protein coding genes and CpG islands provided by the UCSC was used as a basis for data analysis 7 . RNA class assignment of non-protein coding genes was obtained from the Ensembl mm9 annotation 8 .
RNA sequencing reads were mapped using Tophat2 9 and duplicate reads were removed. Cufflinks 10 was used to estimate transcript abundance as fragments per kilobase of exon per million mapped reads (FPKM). The spliced fraction of cardiomyocyte nuclear RNA was used to determine the main cardiomyocyte isoform of each gene. This isoform was used for all subsequent analysis steps. To estimate the detection limit of nuclear RNA-seq, 2 Mb of randomly selected genomic regions outside of genes and flanking regions (± 5 kb) were added to the analysis. The resulting mean FPKM was regarded as detection limit.
ChIP-seq reads were mapped using Bowtie2 11 . To identify genomic regions enriched for H3K27ac MACS2 12 was used. A detection q-value of 0.01 was regarded as significant. GREAT 13 was used to identify peak associated genes and to perform subsequent gene ontology analysis. DeepTools 14 were used for data visualization and normalization.
Prediction of gene expression
The analysis was limited to the main cardiomyocyte gene isoforms. Transcripts with expression values below the detection limit overlapping expressed genes were removed from further analysis steps, leaving 17,915 coding genes for fur further analysis.
To obtain the sum of tag counts we counted reads for each modification using HTSeqcount 15 . For H3K4me3 and H3K27ac reads overlapping the TSS (± 2 kb) were selected to determine reads per kilobase per million mapped reads (RPKM). For H3K36me3, H3K4me1 and H3K27me3 the gene body was used to calculate RPKM values. We normalized the resulting sum of tags to the respective values of whole cell extract chromatin (WCE).
Results from RNA-seq and ChIP-seq experiments were subjected to additive smoothing using an α value. The α value was chosen which maximized the correlation by an iteration over a search space from 0 to 1.
Linear regressions of log-transformed values were used to model the relationship of different histone marks and transcript levels followed by calculation of the pearson coefficient (r 2 ). The sum of log-transformed values of different histones were calculated to increase the goodness of fit. Histone modifications were added subsequently to the combinatorial model according to their coefficient of variation.
External data sets
Previously published MethylC-seq data and ChIP-seq data (H3K27ac, H3K4me3, H3K4me1 and H3K27me3) from adult cardiomyocyte nuclei were analyzed as described 2 . ChIP-seq data for H3K27me3 16 and H3K27ac
17
, methylC-seq data 18 and RNA-seq data 17 derived from adult hearts were reanalyzed. H3K27me3, H3K27ac and H3K4me3 data from in vitro differentiated cardiomyocytes 19 were reanalyzed. RNA-seq data from 8 week old mice of non-cardiac tissues were reanalyzed 20 , too.
Gene ontology analysis
Enriched GO terms of the category 'biological process' were identified by ClueGO 21 . The resulting p-values were corrected for multiple testing using the Benjamini-Hochberg equation.
The most significant term of each group was highlighted. . Results are shown for the cardiomyocyte genes alphaactinin 2 (Actn2), myosin light chain 3 (Myl3), cardiac troponin T type 2 (Tnnt2) and sarcoplasmic reticulum calcium ATPase 2 (Atp2a2). In addition, profiles of the fibroblastspecific transcription factor gene (Tcf21) 22 , the endothelial cell gene VE-cadherin (Cdh5) 23 , the smooth muscle cell gene transgelin (Tagln) 24 and the leukocyte marker gene cluster of differentiation 38 (Cd38) 25 are depicted. Patterns for cardiomyocyte genes were almost identical. Non-cardiomyocyte genes were marked by active histone marks exclusively in in vitro differentiated cardiomyocytes indicating presence of cell types expressing Tcf21, Cdh5, Tagln, or Cd38. Cardiomyocyte genes and Tagln were depleted for H3K27me3 in both data sets. The remaining non-cardiomyocyte genes were enriched for H3K27me3 in cardiomyocyte nuclei but not in in vitro differentiated cardiomyocytes (RPKM: reads per kilobase of exon per million mappable reads). B Summary plots for H3K4me3, H3K27ac and H3K27me3 in cardiomyocyte nuclei and in-vitro differentiated cardiomyocytes 19 . Genes were grouped in quartiles according to expression values in cardiomyocyte nuclei. This genomewide analysis revealed similar enrichment profiles for the indicated histone marks in cardiomyocyte nuclei and in vitro differentiated cardiomyocytes (TSS: transcription start site; TES: transcription end site). C-E Venn diagrams illustrating the overlap of H3K27ac (C), H3K4me3 (D) and H3K27me3 (E) peaks detected in in vitro differentiated cardiomyocytes 19 and cardiomyocyte nuclei. Numbers and percentages indicate the absolute and relative number of peaks. Gene ontology analysis was performed with the nearest peak associated gene (100 kb window). Bar graphs show enriched terms specific for either in vitro differentiated cardiomyocytes (right part) or cardiomyocyte nuclei (left part) determined for 
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